We provide you with 20 years of free, institutional-grade data for AVEO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AVEO. Explore the full financial landscape of AVEO stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| BAILEY MICHAEL P | Derivatives Exercise | 276,746 | 2022-12-22 | ||
| BAILEY MICHAEL P | Open Market Purchase | 15,000 | $6.48 | 2021-09-03 | |
| Ferraresso Michael | Open Market Purchase | 2,608 | $5.75 | 2021-08-11 | |
| Ferraresso Michael | Initial | 2021-03-24 | |||
| Sonsini Peter W. | Open Market Purchase | 1,428,571 | $5.25 | 2020-06-22 | |
| MAKOWER JOSHUA | Open Market Purchase | 1,428,571 | $5.25 | 2020-06-22 | |
| Makhzoumi Mohamad | Open Market Purchase | 1,428,571 | $5.25 | 2020-06-22 | |
| Florence Anthony A. Jr. | Open Market Purchase | 1,428,571 | $5.25 | 2020-06-22 | |
| SANDELL SCOTT D | Open Market Purchase | 1,428,571 | $5.25 | 2020-06-22 | |
| BASKETT FOREST | Open Market Purchase | 1,428,571 | $5.25 | 2020-06-22 | |
| Growth Equity Opportunities Fund IV, LLC | Open Market Purchase | 1,428,571 | $5.25 | 2020-06-22 | |
| BAILEY MICHAEL P | Open Market Purchase | 150,000 | $0.6 | 2019-11-25 |
The information provided in this report about AVEO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
AVEO Pharmaceuticals, Inc(NASDAQ:AVEO) 
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of ren...
Website: http://www.aveooncology.com
Founded: 2001
Full Time Employees: 49 (May 2021)
Sector: Healthcare
Industry: Biotechnology